CLINICAL_TRIALS
trial_result
· 2020-09-02
Clinical Trial Update: Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies. [Phase 3]
Summary
Phase 3 bio-equivalence trial comparing Permethrin 5% cream with Elimite in patients with active scabies has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayne Pharma International Pty Ltd | Conditions: Scabies | Phase 3 | Status: COMPLETED | Results posted: 2020-09-02